Equity
€4,455 from €772,862 in 2017
Equity fell by 99% in 8 years.
North Flow
Lifetime
20 annual accounts with figures on one time axis, 39 filings since 1987peak €240,436 (2023)
€57,945▲ 49.0%
lowest -€176,459 (2018)
€4,213▲ €79,146
peak €772,862 (2017)
€4,455▲ 18×
€299,184▼ 10.8%
peak 1.1 FTE (2020)
-not published
Board2 names since 2014
1 director
Owners
Documentsfilings and deeds
30-07-20261 day before the deadline
2025abbreviated format
Gross margin from €38,888 to €57,945Back to profit: €4,213Equity from €242 to €4,455Cash from €11,615 to €34,686
Key points
from the 2025 annual accountsResult
€4,213 €4,213
Back in profit in 2025, after a loss of €74,933 in 2024.
Debts
€299,184 99% of the balance sheet
Financial debts 63%Suppliers 4%Taxes and wages 5%Other 28%
Of this, €106,985 falls due within a year.
Filings
39 annual accounts since 1987
Four of the last ten came late. The 2024 accounts came latest: 27 days after the end of the period.
Restructuring
2024
Branch transferred to Apotheek Bergendries. Contribution on 27-03-2024.
Position in the sector
€4,455
Less equity than 88% of companies in retail trade. Sector median €315,153 · 13,237 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 1,082 companies had the same profile as North Flow has now. Each dot stands for 3 companies, two years later.
96.9%
were still trading
2.2%
stopped another way
0.8%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,082 companies, not a prediction for North Flow. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 03-12-2014
Auditor
- 6,349 sharesdeed of 22-02-2024
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0429979323
Demerger: Bergendries splits off to Apotheek Bergendries
Capital decrease to €5,420.82 · Capital after the decrease: €5,420.82 · General meeting of 27-03-2024 · Gazette deed
Demerger proposal: Bergendries splits off to Apotheek Bergendries
Appointment: (partner) · Name change: North Flow · Founding capital of €182,765.36, 1,000 shares · Board meeting of 04-01-2024 · Gazette deed
Demerger proposal: Bergendries splits off to Apotheek Bergendries
“Het beheren van aandelen van andere vennootschappen.Dit kan ook gepaard gaan met het actief besturen van de…” (deed in Dutch) · Name change: North Flow · Founding capital of €217,013.05, 1,000 shares · Board meeting of 10-05-2023 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| North Flow Antwerp | €303,640 | €57,945 | 1.5% | - |
| PHARMACIE DEWEZ Visé | €316,582 | €60,835 | 32.4% | - |
| APOTHEEK MALEM Ghent | €326,256 | €59,424 | 64.2% | - |
| APOTHEEK VERONIQUE DOCHY Ghent | €311,576 | €56,546 | 62.1% | - |
| APOTHEEK JOYE Kortrijk | €346,818 | €54,944 | 65.1% | 1.1 |
| ACE PHARMA Fexhe-le-Haut-Clocher | €289,661 | €50,035 | 76.6% | - |
| APOTHEEK PENEL Forest | €277,104 | €62,805 | 4.4% | 0.5 |
These companies have the same main activity as North Flow: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €277,000 and €347,000, founded between 1985 and 1991.
Official details
Source: KBO- Status
- Active since 01-12-1986Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 2 others
- Establishment unit
- 2.041.726.9672018 Antwerp, since 16-01-1989
- Financial year end
- 31 December
- Peppol
- Reachable since 05-09-2026
Annual accounts 2025
- ≈ €280,000estimated
- €303,640▼ 9.5%
- Filing
- Filed on 30-07-2026, 1 day before the end of the filing period
Insights on North Flow
North Flow files the abbreviated format. That format states no turnover. The gross margin fell from €66,054 in 2006 to €57,945 in 2025.
The balance sheet grew most from 2019 to 2020 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about North Flow
- What is the company number of North Flow?
- The company number of North Flow is 0429.979.323. The VAT number is the same number with BE in front: BE 0429.979.323.
- Where is North Flow based?
- The registered office is at Infirmerieplein 7, 2018 Antwerp.Company details
- What does North Flow do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of North Flow?
- North Flow is a private limited company (BV).
- When was North Flow founded?
- North Flow was founded on 01-12-1986.
- Is North Flow still active?
- Yes, North Flow is an active enterprise in the KBO register.
- How many employees does North Flow have?
- North Flow had an average of 1 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
- What is the turnover of North Flow?
- The turnover in financial year 2025 is ≈ €280,000. This figure is estimated from the gross margin of €57,945 and 74 comparable companies (NACE 477). It probably lies between €140,000 and €410,000.
- Is North Flow profitable?
- In financial year 2025, North Flow made a profit of €4,213.
- Where can I find the annual accounts of North Flow?
- North Flow filed 39 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of North Flow due?
- North Flow must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.